Acute Myeloid Leukemia /Features


ISAL 2017: Developments in acute leukemias

The International Symposium on Acute Leukemias (ISAL) 2017 was, as always, filled with data, scientific developments and debate. To capture…

Innovative Medicines Initiative approves €40 million HARMONY project for better care of patients with hematologic malignancies

The Innovative Medicines Initiative (IMI) has approved HARMONY, a project that aims to foster better access and care for patients…

New tyrosine kinase inhibitor shows promise

MRX-2843 is a tyrosine kinase inhibitor that targets the receptor tyrosine kinases MERTK and FLT3. Both MERTK and FLT3 are…

Cytarabine-daunorubicin liposome for injection: a potential new standard of care for elderly patients

The Phase III trial of a novel formulation of cytarabine-daunorubicin encapsulated in a liposome for injection, also referred to as…